Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 1,820 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Health Behavior, Health Care Utilization, Unprotected Sex, Sexually Transmitted Infections
Interventions: SafeSpace Sexual Health, SafeSpace General Health; Behavioral
Lead sponsor: Child Trends; Other
Eligibility: 14 Years to 18 Years · Female only
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Asthma
Interventions: budesonide/formoterol, fluticasone/salmeterol, mometasone/formoterol, Prednisone; Drug
Lead sponsor: Gelb, Arthur F., M.D.; Individual
Eligibility: 10 Years to 95 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2027
U.S. locations: 1
States / cities: Lakewood, California

Conditions: Literacy, Parent-Child Relations, Language Development
Interventions: Reading Bees app and children's book to enhance parent-infant reading quality (0-2 month visit), Reading Bees app and children's book to encourage alternatives to digital media (6-month visit); Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 0 Months to 2 Months
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: E-cigarette Use, Substance Use
Interventions: ENDS Prevention Intervention (TBD); Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 10 Years to 14 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Cocaine Dependence
Interventions: Cocaine, Placebo; Drug
Lead sponsor: Joshua A. Lile, Ph.D.; Other
Eligibility: 21 Years to 45 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Specific Phobia, Animal
Interventions: Telemedicine-Based Virtual Reality Exposure Therapy, Telemedicine-Based Exposure Therapy Using Photos and Videos; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Elevated Triglycerides, Hypertriglyceridemia
Interventions: Average American Diet With SoFAS Replaced With Avocado, Average American Diet; Other
Lead sponsor: Midwest Center for Metabolic and Cardiovascular Research; Other
Eligibility: 21 Years to 74 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Chicago, Illinois • Indianapolis, Indiana

Conditions: Anxiety, Generalized Anxiety Disorder
Interventions: Cannabidiol (CBD)- containing consumer products; Dietary Supplement
Lead sponsor: Radicle Science; Industry
Eligibility: 24 Years to 44 Years · Female only
Enrollment: 1,350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Acute Non-cardioembolic Ischemic Stroke
Interventions: BAY2433334, BAY2433334 matching placebo; Drug · Other
Lead sponsor: Bayer; Industry
Eligibility: 45 Years and older
Enrollment: 1,808 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 5
States / cities: Tampa, Florida • Golden Valley, Minnesota • Kansas City, Missouri + 2 more

Conditions: HIV
Interventions: Standard of Care, FemAALES; Behavioral
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years to 54 Years · Female only
Enrollment: 256 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Healthy
Interventions: 5-13C-Glutamine, Bone marrow aspiration; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Depression
Interventions: SOVA Ambassador, Self-Reflection; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 14 Years to 21 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Stroke, Ischemic, Quadrantanopia, Hemianopsia, Homonymous, Hemianopia, Homonymous, Hemianopia, Hemianopsia, Occipital Lobe Infarct, Visual Field Defect, Peripheral, Vision Loss Partial, Quadrantanopsia, Stroke Hemorrhagic
Interventions: Virtual Reality Driving Task; Other
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Heart Failure With Preserved Ejection Fraction (HFPEF)
Interventions: Ferumoxytol infusion; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 85 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Obesity or Overweight
Interventions: AZD9550, AZD6234, Placebo comparator; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 29
States / cities: Dothan, Alabama • Vestavia Hills, Alabama • Cerritos, California + 26 more

Conditions: Depression, Burnout, Professional
Interventions: Psilocybin, Mindfulness-Based Stress Reduction (MBSR); Drug · Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 25 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Human Papillomavirus Infection, Vaccination Hesitancy
Interventions: PSA Development, HPV vaccination focused social marketing campaign; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Posttraumatic Stress Disorder
Interventions: Trauma Memory Reactivation, Cannabidiol (CBD) Broad-Spectrum Oil, Placebo Oil; Behavioral · Dietary Supplement
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Anterior Cruciate Ligament Injury, Pain; Catheter (Other), Satisfaction, Personal
Interventions: Patient educaiton materials - Print based, Patient educaiton materials - Media based; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: Not listed
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Psoriasis
Interventions: BI 655066 (very high i.v. dose), Placebo, i.v., BI 655066 (high s.c. dose), BI 655066 (low i.v. dose), BI 655066 (high medium i.v. dose), BI 655066 (very low i.v. dose), BI 655066 (low s.c. dose), BI 655066 (high i.v. dose), Placebo, s.c., BI 655066 (low medium i.v. dose); Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 7
States / cities: Burbank, California • Miami, Florida • Port Orange, Florida + 4 more

Conditions: Intraocular Melanoma, Melanoma (Skin)
Interventions: Autologous Dendritic Cells (DC), Fludarabine, Autologous Lymphocyte Infusion (ALI); Biological · Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 16 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Adolescent Mothers, Infant Obesity
Interventions: Tools for Teen Moms; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 14 Years to 19 Years · Female only
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: End Stage Renal Disease, End Stage Liver Disease
Interventions: The Donor App; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 6
States / cities: San Diego, California • New Haven, Connecticut • Chicago, Illinois + 3 more

Conditions: Hernia, Ventral, Hernia Incisional
Interventions: Medium weight or Heavy weight mesh; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,496 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Evaluation of the SafeSpace App Intervention

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

Testing an App-Based Approach to Reading and Screen Time Guidance for Parents of Infants

The Development and Evaluation of a Culturally Grounded ENDS Intervention for Rural Hawaiian Youth

Impact of a Non-Drug Choice on Cocaine Reinforcement

A Randomized Controlled Efficacy Trial of a Telemedicine-based Virtual Reality Clinic for the Treatment of Phobias

Effects of Replacing Energy From Solid Fats and Added Sugars (SoFAS) With Avocado

Evaluation of Effects of CBD Products on Anxiety Among U.S. Women

Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

Females of African American Legacy Empowering Self (FemAALES)

In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells

SOVA Ambassadors Community Setting

Vision Loss Impact on Navigation in Virtual Reality

Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms

On-Q Catheter Caregiver Education

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

Dendritic Cell Vaccination During Lymphoid Reconstruction

Tools For Teen Moms: Reducing Infant Obesity Risk

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

Short Term Outcomes of Heavy-weight Versus Medium-weight Synthetic Mesh